ACHL - Achilles Therapeutics reports Q1 GAAP EPS of -$0.30 May, 08 2024 10:04 AM Achilles Therapeutics plc 2024-05-08 10:04:21 ET More on Achilles Therapeutics Piper downgrades Achilles to neutral, cites latest data Seeking Alpha’s Quant Rating on Achilles Therapeutics Historical earnings data for Achilles Therapeutics Financial information for Achilles Therapeutics For further details see: Achilles Therapeutics reports Q1 GAAP EPS of -$0.30